Ligand profile
XAV
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_3566 — ankyrin repeat family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
XAV- PDB
3uh4- UniProt (similar protein)
O95271- Target protein
- VK055_3566
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 46.0
- −1 ≤ LogP ≤ 5 3.66
- MW ≤ 500 Da 312.3
- LogP ≤ 5 3.66
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 46.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(ccc1c2nc3c(c(n2)O)CSCC3)C(F)(F)Fc1cc(ccc1c2nc3c(c(n2)O)CSCC3)C(F)(F)F
InChI=1S/C14H11F3N2OS/c15-14(16,17)9-3-1-8(2-4-9)12-18-11-5-6-21-7-10(11)13(20)19-12/h1-4H,5-7H2,(H,18,19,20)InChI=1S/C14H11F3N2OS/c15-14(16,17)9-3-1-8(2-4-9)12-18-11-5-6-21-7-10(11)13(20)19-12/h1-4H,5-7H2,(H,18,19,20)
KLGQSVMIPOVQAX-UHFFFAOYSA-NKLGQSVMIPOVQAX-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00644
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand XAV →
- PDB RCSB structure 3uh4 →
- UniProt UniProt O95271 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “XAV”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_3566.
PDB 124
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).